Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations

A case report and a review of the literature

Arwa Z. Al Riyami, Moza Al Salmani, Sabria Al Hashami, Sabah Al Mahrooqi, Sumaiya Al Hinai, Halima Al Balushi, Nihal Al Riyami, V. Gowri, Tamima Al Dughaishi, Saif Al Hosni, Murtadha Al-Khabori, Khalil Al-Farsi, Mohammed Al Huneini, Salam Alkindi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background The management of pregnant women with anti-Jsb is challenging due to the paucity of antigen-negative blood for fetal and neonatal transfusion. Case Report A 29-year-old woman with anti-Jsb was referred for assessment of recurrent fetal losses. With the presence of the sister as a historically matched donor, she was planned for active surveillance for fetal anemia during pregnancy. Study Design and Methods The fetus remained well until 21 weeks of gestation when signs of fetal anemia and early hydrops fetalis were noted. Anti-Jsb titer was at 128. The sister's red blood cells (RBCs) were cross-match incompatible. Urgent intrauterine transfusion (IUT) was performed with washed irradiated maternal RBCs, donated after cessation of heparin. The mother was given intravenous iron (IV-Fe) and continued on weekly recombinant human erythropoietin (rHu-EPO). Results Repeated IUTs were needed every 1 to 3 weeks. Throughout a 7-week period, three maternal donations were performed with total donated whole blood volume of 1250 mL, supporting four IUTs. At 29 weeks of gestation, the procedure was complicated by umbilical cord hematoma necessitating urgent cesarean section. A male newborn was delivered, transfused at birth, and subsequently treated with phototherapy and five top-up transfusions. Conclusion This case represents a successful example of managing hemolytic disease of the fetus due to a rare antibody using maternal blood. It also supports previous data on safety of maternal donations during pregnancy and the use of combination of rHu-EPO and IV-Fe as a supportive measure.

Original languageEnglish
Pages (from-to)238-243
Number of pages6
JournalTransfusion
Volume54
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Intrauterine Blood Transfusion
Blood Donors
Fetus
Mothers
Pregnancy
Erythropoietin
Anemia
Siblings
Erythrocytes
N,N-dimethyl-3,3-diphenyl-1-methylallylamine
Hydrops Fetalis
Phototherapy
Umbilical Cord
Blood Volume
Cesarean Section
Hematoma
Heparin
Pregnant Women
Tissue Donors
Parturition

ASJC Scopus subject areas

  • Hematology
  • Immunology
  • Immunology and Allergy

Cite this

Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations : A case report and a review of the literature. / Al Riyami, Arwa Z.; Al Salmani, Moza; Al Hashami, Sabria; Al Mahrooqi, Sabah; Al Hinai, Sumaiya; Al Balushi, Halima; Al Riyami, Nihal; Gowri, V.; Al Dughaishi, Tamima; Al Hosni, Saif; Al-Khabori, Murtadha; Al-Farsi, Khalil; Al Huneini, Mohammed; Alkindi, Salam.

In: Transfusion, Vol. 54, No. 1, 01.2014, p. 238-243.

Research output: Contribution to journalArticle

@article{aa35ab1e84694318b9b60ad86ce6861e,
title = "Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: A case report and a review of the literature",
abstract = "Background The management of pregnant women with anti-Jsb is challenging due to the paucity of antigen-negative blood for fetal and neonatal transfusion. Case Report A 29-year-old woman with anti-Jsb was referred for assessment of recurrent fetal losses. With the presence of the sister as a historically matched donor, she was planned for active surveillance for fetal anemia during pregnancy. Study Design and Methods The fetus remained well until 21 weeks of gestation when signs of fetal anemia and early hydrops fetalis were noted. Anti-Jsb titer was at 128. The sister's red blood cells (RBCs) were cross-match incompatible. Urgent intrauterine transfusion (IUT) was performed with washed irradiated maternal RBCs, donated after cessation of heparin. The mother was given intravenous iron (IV-Fe) and continued on weekly recombinant human erythropoietin (rHu-EPO). Results Repeated IUTs were needed every 1 to 3 weeks. Throughout a 7-week period, three maternal donations were performed with total donated whole blood volume of 1250 mL, supporting four IUTs. At 29 weeks of gestation, the procedure was complicated by umbilical cord hematoma necessitating urgent cesarean section. A male newborn was delivered, transfused at birth, and subsequently treated with phototherapy and five top-up transfusions. Conclusion This case represents a successful example of managing hemolytic disease of the fetus due to a rare antibody using maternal blood. It also supports previous data on safety of maternal donations during pregnancy and the use of combination of rHu-EPO and IV-Fe as a supportive measure.",
author = "{Al Riyami}, {Arwa Z.} and {Al Salmani}, Moza and {Al Hashami}, Sabria and {Al Mahrooqi}, Sabah and {Al Hinai}, Sumaiya and {Al Balushi}, Halima and {Al Riyami}, Nihal and V. Gowri and {Al Dughaishi}, Tamima and {Al Hosni}, Saif and Murtadha Al-Khabori and Khalil Al-Farsi and {Al Huneini}, Mohammed and Salam Alkindi",
year = "2014",
month = "1",
doi = "10.1111/trf.12331",
language = "English",
volume = "54",
pages = "238--243",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations

T2 - A case report and a review of the literature

AU - Al Riyami, Arwa Z.

AU - Al Salmani, Moza

AU - Al Hashami, Sabria

AU - Al Mahrooqi, Sabah

AU - Al Hinai, Sumaiya

AU - Al Balushi, Halima

AU - Al Riyami, Nihal

AU - Gowri, V.

AU - Al Dughaishi, Tamima

AU - Al Hosni, Saif

AU - Al-Khabori, Murtadha

AU - Al-Farsi, Khalil

AU - Al Huneini, Mohammed

AU - Alkindi, Salam

PY - 2014/1

Y1 - 2014/1

N2 - Background The management of pregnant women with anti-Jsb is challenging due to the paucity of antigen-negative blood for fetal and neonatal transfusion. Case Report A 29-year-old woman with anti-Jsb was referred for assessment of recurrent fetal losses. With the presence of the sister as a historically matched donor, she was planned for active surveillance for fetal anemia during pregnancy. Study Design and Methods The fetus remained well until 21 weeks of gestation when signs of fetal anemia and early hydrops fetalis were noted. Anti-Jsb titer was at 128. The sister's red blood cells (RBCs) were cross-match incompatible. Urgent intrauterine transfusion (IUT) was performed with washed irradiated maternal RBCs, donated after cessation of heparin. The mother was given intravenous iron (IV-Fe) and continued on weekly recombinant human erythropoietin (rHu-EPO). Results Repeated IUTs were needed every 1 to 3 weeks. Throughout a 7-week period, three maternal donations were performed with total donated whole blood volume of 1250 mL, supporting four IUTs. At 29 weeks of gestation, the procedure was complicated by umbilical cord hematoma necessitating urgent cesarean section. A male newborn was delivered, transfused at birth, and subsequently treated with phototherapy and five top-up transfusions. Conclusion This case represents a successful example of managing hemolytic disease of the fetus due to a rare antibody using maternal blood. It also supports previous data on safety of maternal donations during pregnancy and the use of combination of rHu-EPO and IV-Fe as a supportive measure.

AB - Background The management of pregnant women with anti-Jsb is challenging due to the paucity of antigen-negative blood for fetal and neonatal transfusion. Case Report A 29-year-old woman with anti-Jsb was referred for assessment of recurrent fetal losses. With the presence of the sister as a historically matched donor, she was planned for active surveillance for fetal anemia during pregnancy. Study Design and Methods The fetus remained well until 21 weeks of gestation when signs of fetal anemia and early hydrops fetalis were noted. Anti-Jsb titer was at 128. The sister's red blood cells (RBCs) were cross-match incompatible. Urgent intrauterine transfusion (IUT) was performed with washed irradiated maternal RBCs, donated after cessation of heparin. The mother was given intravenous iron (IV-Fe) and continued on weekly recombinant human erythropoietin (rHu-EPO). Results Repeated IUTs were needed every 1 to 3 weeks. Throughout a 7-week period, three maternal donations were performed with total donated whole blood volume of 1250 mL, supporting four IUTs. At 29 weeks of gestation, the procedure was complicated by umbilical cord hematoma necessitating urgent cesarean section. A male newborn was delivered, transfused at birth, and subsequently treated with phototherapy and five top-up transfusions. Conclusion This case represents a successful example of managing hemolytic disease of the fetus due to a rare antibody using maternal blood. It also supports previous data on safety of maternal donations during pregnancy and the use of combination of rHu-EPO and IV-Fe as a supportive measure.

UR - http://www.scopus.com/inward/record.url?scp=84891841073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891841073&partnerID=8YFLogxK

U2 - 10.1111/trf.12331

DO - 10.1111/trf.12331

M3 - Article

VL - 54

SP - 238

EP - 243

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 1

ER -